T2D Research

T2D Cytotoxic T-Cell Expansion

Properties2
tagsconcept, type-2-diabetes, pbmc, immunology, transcriptomics
aliasesT2D Cytotoxic T-Cell Expansion

3 min read

T2D Cytotoxic T-Cell Expansion

Gu et al. report that T2D PBMCs show increased cytotoxic T-cell activation and clonal expansion, especially in CD4 cytotoxic T cells and CD8 effector memory T cells.

Key Findings

  • Gu et al. 2024 T-cell reclustering identified CD4 naive, CD4 central memory, CD4 regulatory, CD4 cytotoxic, CD8 naive, CD8 central memory, CD8 effector memory, gamma-delta T, and MAIT subsets.
  • Gu et al. 2024 reported CD4 naive T cells were significantly lower in T2D than non-diabetes controls.
  • Gu et al. 2024 reported higher cytotoxicity scores based on PRF1, GZMH, and GZMK in CD4 cytotoxic T cells, CD8 effector memory T cells, and gamma-delta T cells from T2D participants.
  • Gu et al. 2024 reported elevated KLRG1 expression in T2D CD8 effector memory cells, suggesting a more senescent or repeatedly stimulated phenotype.
  • Gu et al. 2024 TCR analysis showed significant clonal expansion in cytotoxic T cells from T2D participants, with higher Gini index values than non-diabetes controls.
  • Li et al. 2025 identified eight T-cell subtypes and reported higher cytotoxic CD8+ T-cell and naive CD8+ T-cell proportions in T2D, with lower regulatory CD4+ T-cell proportions.
  • In the later immunometabolic subtype analysis, Li et al. 2025 reported lower cytotoxic CD8+ T-cell proportions in subtypes A and C than healthy controls, while group C also had lower memory and naive CD8+ T-cell proportions.
  • These two Li et al. 2025 statements are not the same comparison: the first pools all T2D samples, while the second compares metabolically defined T2D subtypes against controls. The pooled increase could be driven by subtype B or by weighting/cell-level aggregation, but the paper text does not make this reconciliation explicit.
  • Li et al. 2025 reported subtype-specific transcription-factor activity in cytotoxic and memory T-cell compartments, including EPAS1 in subtype A and BCL11A/TBX21-related patterns in subtype C.
  • Zhao and Fang 2025 identified two CD4+ T-cell clusters and three CD8+ T-cell clusters, with CD4+ T cells tending toward memory and naive states and CD8+ T cells tending toward effector and memory states.
  • Zhao and Fang 2025 reported 119 T-cell DEGs in T2DM versus healthy controls, including GO enrichment for T-cell receptor signaling and immune response-regulating signaling.
  • Zhao and Fang 2025 reported HALLMARK_TNFA_SIGNALING_VIA_NFKB enrichment in T-cell DEGs and identified TNFRSF1A as a core network interaction gene in a clinically associated WGCNA module.
  • Zhao and Fang 2025 reported that T cells in T2DM participants were more likely to be in G1, S, and G2M states than T cells from healthy participants, interpreting this as active proliferation.

Interpretation

  • The Gu et al. 2024 data support a model in which T2D is associated with persistent cytotoxic lymphocyte stimulation in peripheral blood.
  • Gu et al. 2024 connects this adaptive immune pattern to inflammatory monocyte signaling, but it does not prove whether monocyte changes cause T-cell expansion or whether both reflect another upstream T2D-related driver.
  • Li et al. 2025 complicates a simple “T2D equals cytotoxic expansion” narrative by showing that cytotoxic CD8+ T-cell patterns may differ across T-cell metabolic subtypes.
  • For manuscript use, cytotoxic T-cell findings should be framed as cohort- and subtype-sensitive rather than universally directional until additional studies are ingested.
  • Zhao and Fang’s T-cell results overlap inflammatory and activation themes in other T2D PBMC studies, but the paper does not include TCR clonality and should not be treated as direct evidence for cytotoxic clonal expansion.

Manuscript Use

Sources

Graph View

Backlinks